Actively Recruiting
Molecularly Redefining Small Bowel Adenocarcinoma to Accelerate Precision Patient Care
Led by Copenhagen University Hospital at Herlev · Updated on 2024-01-31
500
Participants Needed
3
Research Sites
521 weeks
Total Duration
On this page
Sponsors
C
Copenhagen University Hospital at Herlev
Lead Sponsor
A
Aarhus University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Small bowel adenocarcinoma is a rare malignancy, and there is limited knowledge about its optimal clinical management and molecular background. The SBAMOL study is an observational biomarker study that aims to identify prognostic and predictive biomarkers. This effort is intended to lay the groundwork for personalized medicine tailored to this specific patient group.
CONDITIONS
Official Title
Molecularly Redefining Small Bowel Adenocarcinoma to Accelerate Precision Patient Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with histologically verified small bowel adenocarcinoma
- Patients older than 18 years
You will not qualify if you...
- Insufficient material for molecular testing
- Patients registered in Vævsanvendelsesregistret who have opted out of research use of their biological material
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Department of Oncology, Aarhus University Hospital
Aarhus N, Denmark, 8200
Actively Recruiting
2
Department Surgical Gastroenterology, Copenhagen University Hospital - Rigshospitalet
Copenhagen Ø, Denmark, 2100
Actively Recruiting
3
Department of Oncology Copenhagen University Hospital - Herlev and Gentofte
Herlev, Denmark, 2730
Actively Recruiting
Research Team
D
Dan Høgdall, MD PhD
CONTACT
J
Jakob HV Schou, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here